Related Experiment Video
Updated: Jan 21, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease
Harry Petrushkin1,2, Paul J Norman3, Emma Lougee4
1Moorfields Eye Hospital National Health Service Foundation Trust, Medical Retina Department, London EC1V 2PD, United Kingdom.
Insights
This study identifies specific KIR3DL1/S1 gene variants that influence Behçet disease risk and severity. Certain KIR3DL1/S1 alleles increase the likelihood of developing Behçet disease and eye complications, while others offer protection.
Area of Science:
- Immunogenetics
- Autoinflammatory Diseases
- Human Genetics
Background:
- Behçet disease is a chronic autoinflammatory syndrome with a known association with the HLA-B*51 gene.
- The role of killer cell immunoglobulin-like receptors (KIRs) in Behçet disease pathogenesis remains incompletely understood.
Purpose of the Study:
- To investigate the association between KIR3DL1/S1 allelic variations and Behçet disease risk in a UK cohort.
- To explore the influence of these KIR variants on disease phenotype, specifically mucocutaneous and ophthalmic manifestations.
Main Methods:
- Analysis of a UK cohort comprising 267 Behçet disease patients and 445 healthy controls.
- HLA-B*51 genotyping and KIR3DL1/S1 allele-level analysis were performed.
- Statistical analysis, including Bonferroni-Dunn correction, was used to determine significance.
Main Results:
- HLA-B*51 was confirmed as a significant genetic risk factor for Behçet disease (Pc=0.0192, OR=1.92).
- Low-expressing KIR3DL1/S1 alleles combined with KIR3DS1 increased Behçet disease risk (Pc=0.0040, OR=2.47) and ophthalmic disease risk (P=1.2 × 10⁻⁵, OR=3.92).
- High-expressing KIR3DL1/S1 alleles with null KIR3DL1 reduced disease risk (Pc=0.0350, OR=0.53) and the risk of purely mucocutaneous disease (P=0.0048, OR=0.45).
Conclusions:
- KIR3DL1/S1 allelic variation significantly impacts Behçet disease susceptibility and clinical presentation.
- The interaction between HLA-B*51 and KIR3DL1/S1 genotypes may play a crucial role in Behçet disease pathogenesis.
- These findings offer novel insights into the genetic underpinnings of Behçet disease and its diverse manifestations.
Abstract:
Behçet disease is a chronic, relapsing-remitting autoinflammatory syndrome with a strong HLA-B*51 association. In this paper, we describe a human cohort of 267 individuals with Behçet disease and 445 matched controls from a tertiary referral center in the U.K. HLA-B*51 was confirmed as a genetic risk factor in this group (p = 0.0006, Bonferroni-Dunn correction for multiple testing [Pc] = 0.0192, odds ratio [OR] 1.92, 95% confidence interval [CI] 1.33-2.76). KIR3DL1/S1 allele-level analysis indicated that low-expressing KIR3DL1/S1 alleles in combination with KIR3DS1 increased the risk of developing Behçet disease (KIR3DL1LOW/KIR3DS1: p = 0.0004, Pc = 0.0040, OR 2.47, 95% CI 1.43-4.25), whereas high-expressing KIR3DL1/S1 alleles in combination with a null-expressing KIR3DL1 reduced the risk of disease (KIR3DL1HIGH/KIR3DL1NULL: p = 0.0035, Pc = 0.0350, OR 0.53, 95% CI 0.33-0.87). Behçet disease can manifest as a purely mucocutaneous disease or can involve other organ systems such as the eyes. In the U.K. cohort studied in this study, KIR3DL1LOW/KIR3DS1 increased the risk of ophthalmic disease (p = 1.2 × 10-5, OR 3.92, 95% CI 2.06-7.47), whereas KIR3DL1HIGH/KIR3DL1NULL reduced the risk of having purely mucocutaneous disease (p = 0.0048, OR 0.45, 95% CI 0.25-0.81). To our knowledge, this is the first analysis of KIR3DL1/S1 allelic variation in Behçet disease and may provide insight into the pathogenic role of HLA-B*51 and its interaction with KIR3DL1/S1.
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Fruit Development, Structure, and Function
Sustainable Development
Cellular Differentiation
A zygote is a...
Differential Leveling

